Core Viewpoint - The Supervisory Board of Shenzhen Kaili Biomedical Technology Co., Ltd. has reviewed the 2025 Employee Stock Ownership Plan and concluded that it complies with relevant laws and regulations, and will not harm the interests of the company or its shareholders [1][2]. Summary by Sections Compliance and Legality - The company does not fall under any prohibitive conditions for implementing the employee stock ownership plan as per the relevant guidelines and regulations [1]. - The procedures for drafting the 2025 Employee Stock Ownership Plan and related documents are legal and effective [2]. Employee Involvement - The plan has been developed with sufficient consultation from employee representatives, ensuring that the decision-making process is legal and does not harm the interests of the company or its shareholders [2]. Eligibility and Benefits - The proposed participants in the employee stock ownership plan meet the eligibility criteria set forth in the relevant guidelines and regulations [2]. - Implementing this plan is expected to foster a mechanism for sharing achievements and risks between talented employees and shareholders, enhancing employee engagement, optimizing compensation structures, and promoting long-term stable development and shareholder value [2].
开立医疗: 监事会关于公司 2025 年员工持股计划相关事项的核查意见